Vogt-Koyanagi-Harada syndrome is a rare disease that occurs commonly in pigmented individuals of Asian origin. A 25-year female presented in medical outpatient department (OPD) of Al-Khidmat Teaching Hospital, Mansoora, Lahore with headache and neck stiffness. She was referred to eye OPD for the complaint of decreased vision. On examination, there was 6/24 vision, sluggish pupillary reaction and disc hyperemia in both eyes. She was treated as a case of optic neuritis. Few days later, she developed bilateral panuveitis, shallow exudative detachments and alopecia. Clinical picture with normal magnetic resonance imaging (MRI) and laboratory tests helped us in reaching the diagnosis of Vogt-Koyanagi-Harada syndrome.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.29271/jcpsp.2018.04.325 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Case of Bilateral Acute Angle Closure Glaucoma in a Patient with Vogt-Koyanagi-Harada Syndrome.
Korean J Ophthalmol
December 2024
Department of Ophthalmology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
Developing the biomarker panels and drugs by proteomic analysis for autoimmune uveitis and posterior scleritis.
iScience
December 2024
Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.
Autoimmune uveitis and posterior scleritis are ocular diseases caused by immune dysregulation. Their pathogenesis remains elusive, and delayed diagnosis can exacerbate vision loss. Our study analyzed proteomic profiles of 190 patients with Behcet's disease uveitis, posterior scleritis, and Vogt-Koyanagi-Harada syndrome.
View Article and Find Full Text PDFPattern of Uveitis in Northern Vietnam.
Ocul Immunol Inflamm
December 2024
Department of Ophthalmology, Hanoi Medical University, Hanoi, Vietnam.
Purpose: To characterize the spectrum of uveitis in patients visiting three tertiary hospitals in Hanoi, Vietnam.
Methods: This study collected prospective and multicenter data from patients diagnosed with uveitis at three tertiary hospitals in Hanoi City, Vietnam, between January 2022 and January 2024. Data on age, sex, clinical and laboratory findings, and etiology were collected.
Mycophenolate Mofetil-Induced Lymphoproliferative Disorder in a Young Adult With Chronic Posterior Uveitis.
J Vitreoretin Dis
October 2024
Michigan State University College of Human Medicine, Grand Rapids, MI, USA.
To present a case of a young adult with bilateral chronic posterior uveitis resulting from Vogt-Koyanagi-Harada (VKH) disease treated with mycophenolate mofetil who subsequently developed vitreoretinal lymphoma in the right eye. A case and its findings were analyzed. A 34-year-old Hispanic woman presented with an 8-year history of chronic recurrent posterior uveitis in both eyes secondary to VKH disease.
View Article and Find Full Text PDFReduced contrast sensitivity function and outer retina thickness in convalescent Vogt-Koyanagi-Harada disease.
Eye (Lond)
February 2025
National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
Article Synopsis
- The study assessed contrast sensitivity function (CSF) in patients recovering from Vogt-Koyanagi-Harada (VKH) disease, particularly focusing on those with and without sunset glow fundus (SGF).
- Patients with SGF exhibited significantly impaired CSF compared to normal controls, especially at medium and high spatial frequencies, while no notable differences were found between the non-SGF group and controls.
- The results indicate that despite good visual acuity recovery, both CSF and outer retinal thickness were reduced in VKH patients, suggesting that CSF is a valuable measure for evaluating functional vision in these cases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!